- Forums
- ASX - By Stock
- Ann: Promising Interim Results from TAVR Animal Study
One question;What happened to sheep number 5?
-
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.02 |
Change
-0.890(8.98%) |
Mkt cap ! $196.8M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $200.2K | 21.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22 | $9.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.57 | 98 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 432 | 9.200 |
1 | 397 | 9.100 |
1 | 298 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
Price($) | Vol. | No. |
---|---|---|
8.570 | 98 | 1 |
9.000 | 112 | 1 |
9.100 | 3555 | 1 |
9.850 | 1000 | 1 |
9.910 | 231 | 2 |
Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online